IOSP Innospec Inc

Price (delayed)

$81.17

Market cap

$2.02B

P/E Ratio

105.42

Dividend/share

$1.63

EPS

$0.77

Enterprise value

$1.8B

Innospec Inc. is an international specialty chemicals company with approximately 1900 employees in 24 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, ...

Highlights
The quick ratio is up by 10% YoY
The equity is up by 9% YoY and by 2.8% from the previous quarter
The stock's price to earnings (P/E) is 158% more than its 5-year quarterly average of 41.0 and 44% more than its last 4 quarters average of 73.4
Innospec's net income has plunged by 87% YoY and by 29% from the previous quarter

Key stats

What are the main financial stats of IOSP
Market
Shares outstanding
24.83M
Market cap
$2.02B
Enterprise value
$1.8B
Valuations
Price to earnings (P/E)
105.42
Price to book (P/B)
1.56
Price to sales (P/S)
1.13
EV/EBIT
195.48
EV/EBITDA
33.8
EV/Sales
1
Earnings
Revenue
$1.79B
Gross profit
$508.6M
Operating income
$166.8M
Net income
$19.3M
EBIT
$9.2M
EBITDA
$53.2M
Free cash flow
$72.8M
Per share
EPS
$0.77
EPS diluted
$0.78
Free cash flow per share
$2.92
Book value per share
$51.9
Revenue per share
$71.81
TBVPS
$53.34
Balance sheet
Total assets
$1.81B
Total liabilities
$504.6M
Debt
$49.3M
Equity
$1.3B
Working capital
$632.3M
Liquidity
Debt to equity
0.04
Current ratio
2.87
Quick ratio
1.79
Net debt/EBITDA
-4.08
Margins
EBITDA margin
3%
Gross margin
28.4%
Net margin
1.1%
Operating margin
9.3%
Efficiency
Return on assets
1.1%
Return on equity
1.5%
Return on invested capital
1.3%
Return on capital employed
0.6%
Return on sales
0.5%
Dividend
Dividend yield
2.01%
DPS
$1.63
Payout ratio
211.7%

IOSP stock price

How has the Innospec stock price performed over time
Intraday
-0.33%
1 week
2.29%
1 month
-8.03%
1 year
-23.72%
YTD
-26.25%
QTD
-3.47%

Financial performance

How have Innospec's revenue and profit performed over time
Revenue
$1.79B
Gross profit
$508.6M
Operating income
$166.8M
Net income
$19.3M
Gross margin
28.4%
Net margin
1.1%
Innospec's net income has plunged by 87% YoY and by 29% from the previous quarter
The net margin has dropped by 86% year-on-year and by 27% since the previous quarter
IOSP's gross profit is down by 12% year-on-year
The gross margin is down by 7% YoY

Price vs fundamentals

How does IOSP's price correlate with its fundamentals

Growth

What is Innospec's growth rate over time

Valuation

What is Innospec stock price valuation
P/E
105.42
P/B
1.56
P/S
1.13
EV/EBIT
195.48
EV/EBITDA
33.8
EV/Sales
1
The stock's price to earnings (P/E) is 158% more than its 5-year quarterly average of 41.0 and 44% more than its last 4 quarters average of 73.4
The company's EPS has shrunk by 87% YoY and by 29% QoQ
The P/B is 29% less than the 5-year quarterly average of 2.2 and 22% less than the last 4 quarters average of 2.0
The equity is up by 9% YoY and by 2.8% from the previous quarter
The price to sales (P/S) is 25% lower than the 5-year quarterly average of 1.5 and 19% lower than the last 4 quarters average of 1.4
Innospec's revenue has decreased by 5% YoY

Efficiency

How efficient is Innospec business performance
The company's return on sales has shrunk by 95% YoY and by 58% QoQ
IOSP's return on invested capital has dropped by 95% year-on-year and by 57% since the previous quarter
Innospec's ROE has plunged by 88% YoY and by 32% from the previous quarter
IOSP's ROA has dropped by 88% year-on-year and by 27% since the previous quarter

Dividends

What is IOSP's dividend history
DPS
$1.63
Dividend yield
2.01%
Payout ratio
211.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Innospec financials performed over time
The quick ratio is up by 10% YoY
The current ratio has grown by 9% YoY and by 5% from the previous quarter
The debt is 96% smaller than the equity
The debt rose by 11% since the previous quarter and by 2.5% year-on-year
The equity is up by 9% YoY and by 2.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.